<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="186548">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00665262</url>
  </required_header>
  <id_info>
    <org_study_id>R-06-159</org_study_id>
    <secondary_id>12177</secondary_id>
    <nct_id>NCT00665262</nct_id>
  </id_info>
  <brief_title>The Effect of the Combined Use of Naloxone and Tramacet on Postoperative Analgesia in the Elderly</brief_title>
  <official_title>The Effect of the Combined Use of Naloxone and Tramacet on Postoperative Analgesia in Elderly Patients Having Joint Replacement Surgery: a Prospective Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ten patients 70 years and older having elective total hip/knee replacement surgery will be
      recruited to receive a continuous IV infusion of naloxone and oral tramacet for analgesia.
      Postoperative analgesia, satisfaction, side effects, need for rescure analgesia, and length
      of stay.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2006</start_date>
  <completion_date>December 2008</completion_date>
  <primary_completion_date type="Actual">September 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>opoid use post knee/hip arthroplasty</measure>
    <time_frame>post-op period</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of visual analogue scale scores greater than 4</measure>
    <time_frame>post-op period</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Arthroplasty</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>comibined use of tramacet and naloxone infusion perioperatively</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tramacet</intervention_name>
    <description>2 tablets every 6 hours for 5 days</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged 70 years or older able to give consent able to communicate in English having
             elective hip/knee arthroplasty ASA physical status 1-3

        Exclusion Criteria:

          -  allergies to any of the following: naloxone, tramacet, NSAIDs, sulpha, or local
             anesthesic contraindication to spinal anesthesia contraindication to use of tramacet
             or celebrex ASA physical status4 chronic opiod use chronic pain syndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>St. Joseph's Health Care</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 4V2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2008</verification_date>
  <lastchanged_date>April 18, 2008</lastchanged_date>
  <firstreceived_date>April 18, 2008</firstreceived_date>
  <responsible_party>
    <name_title>Dr Ngozi Imasogie</name_title>
    <organization>Lawson Health Research Institute</organization>
  </responsible_party>
  <keyword>analgesia</keyword>
  <keyword>hip arthroplasty</keyword>
  <keyword>knee arthroplasty</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Naloxone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
